6505-01-069-3244 ( NDC00591-5538-12 , QUINAGLUTE DURA-TAB , NDC50419-0101-12 , NDC00005-3113-48 )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-069-3244 6505 010693244 QUINIDINE GLUCONATE EXTENDED-REL 4258
NSN Features
MRC Parameter Characteristics
FEAT SPECIAL FEATURES WITH CHILD RESISTANT CLOSURE;LONG ACTION METHOD:EXTENDED RELEASE;ADMINISTRATION:ORAL NONCHEWABLE;
CQCT PRIMARY CONTAINER TYPE BOTTLE
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
CRLK PRIMARY CONTAINER CONTENT QUANTITY 120.000 TABLETS
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
NDC00591-5538-12 62051 A 2 3 6 54
QUINAGLUTE DURA-TAB 59463 A 1 5 6 54
NDC50419-0101-12 59463 A 2 3 6 54
NDC00005-3113-48 06404 A 2 3 6 54
Manufacturers
Part SKU Cage Manufacturer Type Status
NDC00591-5538-12 62051 DANBURY PHARMACAL INC A A
QUINAGLUTE DURA-TAB 59463 BAYER HEALTHCARE PHARMACEUTICALS A A
NDC50419-0101-12 59463 BAYER HEALTHCARE PHARMACEUTICALS A A
NDC00005-3113-48 06404 AMERICAN CYANAMID CO A A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
U X A 1 12/13/1 P 3004909120 4258
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
VA V K U/I CONTAINS 120 TT
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A U P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
VA G36 Y 0 BT M U V
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC